Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Antibe Therapeutics Inc(Pre-Merger)
ATBPF
Healthcare
Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,...
otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:ATBPF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(0)
•••
Gessurong
X
View Profile
View Bullboard History
Comment by
Gessurong
on Apr 10, 2024 9:56am
RE:draw no conclusions
(1202)
•••
Duster340
X
View Profile
View Bullboard History
Post by
Duster340
on Apr 10, 2024 9:18am
They bought🃏🀄
themselves eight more days. they are just playing out there cards, maybe drag out another payday or two. stick a fork in antibe they are done.
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Apr 10, 2024 8:15am
RE:Lol mushy Nov 3 2021
My offer still stands to help Mr Mugsy, with some $$ for food provided that he/she admits in wrting of her/his total investemt incompetance. Come on Mr Mugsy you can do it ten years later.
(15)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Post by
SimonSaysLues
on Apr 09, 2024 11:49pm
Lol mushy Nov 3 2021
If you are looking for potential items that could move the stock ... here are a few things to think about ... 1. 346 (acute) fast-track application and then a further acceptance from FDA 60 days later
...more
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Apr 09, 2024 11:46pm
RE:RE:Expected PR = Good News
MrMugsy, delutional as usual and lost all is cash. Anyone agrees with Mugsy? oh..I forgot mugsy has secret aliases>
(0)
•••
Gessurong
X
View Profile
View Bullboard History
Comment by
Gessurong
on Apr 09, 2024 11:15pm
RE:RE:Expected PR = Good News
You never mentioned bankruptcy and delisting. Why would you buy shares last week if bankruptcy was expected?
(15)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Comment by
SimonSaysLues
on Apr 09, 2024 10:44pm
RE:RE:Expected PR = Good News
Unexpected lol. At 2 cents your big mouth will still be flapping. Scamming Bafoons are still unchecked. Welcome to Canadian small cap! Good for you mushy. Give the
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Comment by
MrMugsy
on Apr 09, 2024 10:10pm
RE:Expected PR = Good News
Now some very important cards to play. The only unexpected part of this game is the FDA hold. To do blood testing or not? That is likely the question. Can we get to resolution quickly
...more
(128)
•••
MrMugsy
X
View Profile
View Bullboard History
Post by
MrMugsy
on Apr 09, 2024 10:06pm
hahaha !
Best game ever !!!! Hold on tight as we loop-d-loop !!!!
(3)
•••
Chianchin
X
View Profile
View Bullboard History
Comment by
Chianchin
on Apr 09, 2024 7:37pm
RE:RE:Expected PR = Good News
Mr Mugsy the know it all, is happy as all of his cash stash is locked and lost in ATE. If I may, I suggest that we start to help Mr Mugsy but only If .....I repeat if ......Mugsy admits his/her
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 09, 2024 7:01pm
New Press Release - Antibe Announces Granting of Initial Order Under Companies' Creditors Arrangement Act
Antibe Therapeutics Inc. (“Antibe” or the “Company”) (TSX: ATE, OTCQX: ATBPF) announced that its previously announced application for an Initial Order under the Companies' Creditors Arrangement Act (the "CCAA"), has been granted by the Ontario Superior Court of Justice (Commercial List) (the...
read article.
(15)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Comment by
SimonSaysLues
on Apr 09, 2024 4:29pm
RE:Expected PR = Good News
Everything's good news on this board. Nothing is bad and its just a regular day. Managenent is not incompetent. My guess is you are still holding lots. Good for you!!
(17)
•••
mstrmnds
X
View Profile
View Bullboard History
Post by
mstrmnds
on Apr 09, 2024 3:51pm
Expected PR = Good News
We knew CCAA would be enacted to protect assets from creditors. This is good news. Nuance will join the list of creditors and payout (if any) will be dragged out. Non-essential directors
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 09, 2024 11:26am
New Press Release - Canadian Investment Regulatory Organization Trade Resumption - ATE
VANCOUVER, BC, April 9, 2024 /CNW/ - Trading resumes in:Company: Antibe Therapeutics Inc.TSX-Venture Symbol: ATEAll Issues: YesResumption (ET): 9:15 AMCIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are...
read article.
(15)
•••
SimonSaysLues
X
View Profile
View Bullboard History
Post by
SimonSaysLues
on Apr 09, 2024 10:51am
It's Beautiful , beautiful day folks
Thanks to whoever bought my shares yesterday on my day trade. Remember Las week I said this would go to creditor protection. Oh and mugsy, you are the biggest.....
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >